Recursion Pharmaceuticals Plunges 22% in May: How to Play the Stock - MSN
3 days ago • Google News
Recursion Pharmaceuticals Inc (RXRX)
US$ 5.841.92%
Price Chart
Key Statistics
Market Cap
$ 1.66B
P/E Ratio
0.00
Revenue (TTM)
$ 59.79M
Volume
13.44M
52W High
$ 12.36
52W Low
$ 3.79
Dividend Yield
0.00%
Beta
0.98
Technicals
50-Day MA
5.3236
200-Day MA
6.5851
52 Week High
12.36
52 Week Low
3.79
About RXRX
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, au.
Employees
800
Headquarters
Salt Lake City, UT
CEO
Dr. Christopher C. Gibson Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg